InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Gelder Mark S. MD, Directeur Médical. Director active across 1 companies, notably Onconova Therapeutics, Inc.. Cumulatively, 2 filings have been logged. Total volume traded: €17k. The latest transaction was filed on 28 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€8,5572,381 shares@ €3.5939100.0% of flow
Common Stock
SEC:0001179110-21-008981·
Ideal exit: 25 Jun 2022 (T+270)
€8,5572,381 shares@ €3.593950.0% of flow
Common Stock
SEC:0001179110-21-008981:0·
Ideal exit: 25 Jun 2022 (T+270)
2 of 2 declarations
About Gelder Mark S. MD
Mark S. Gelder is the Chief Medical Officer at Onconova Therapeutics, Inc. He is responsible for the company's medical and clinical strategies, ensuring innovation in treatment development. His medical expertise is essential for Onconova's mission.
